I think the number in the commentary is correct (and the figure in the table is incorrect).
And as mentioned that's over the European summer which is a very quiet time.
I think that the sales for this current FY will be much better than ever, but not break even. Maybe 2-3 million.
There is capital coming in from exercise of June options which I think will be the last funding required.
I think the company will be sold. Not before an FDA decision however. If they decide to continue as a going concern because they are doing very well, then the exercise of options over the following years will give then additional capital. But I personally think that those options will only vest in a sale.
What I really don't understand is this selling below 1 cent. I really don't get it.
OSL Price at posting:
0.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)